Literature DB >> 26974425

Pancreatic Islet Responses to Metabolic Trauma.

Susan J Burke1, Michael D Karlstad, J Jason Collier.   

Abstract

Carbohydrate, lipid, and protein metabolism are largely controlled by the interplay of various hormones, which includes those secreted by the pancreatic islets of Langerhans. While typically representing only 1% to 2% of the total pancreatic mass, the islets have a remarkable ability to adapt to disparate situations demanding a change in hormone release, such as peripheral insulin resistance. There are many different routes to the onset of insulin resistance, including obesity, lipodystrophy, glucocorticoid excess, and the chronic usage of atypical antipsychotic drugs. All of these situations are coupled to an increase in pancreatic islet size, often with a corresponding increase in insulin production. These adaptive responses within the islets are ultimately intended to maintain glycemic control and to promote macronutrient homeostasis during times of stress. Herein, we review the consequences of specific metabolic trauma that lead to insulin resistance and the corresponding adaptive alterations within the pancreatic islets.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26974425      PMCID: PMC4987253          DOI: 10.1097/SHK.0000000000000607

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  119 in total

Review 1.  Sweet changes: glucose homeostasis can be altered by manipulating genes controlling hepatic glucose metabolism.

Authors:  James J Collier; Donald K Scott
Journal:  Mol Endocrinol       Date:  2003-12-23

Review 2.  Cushing's syndrome: update on signs, symptoms and biochemical screening.

Authors:  Lynnette K Nieman
Journal:  Eur J Endocrinol       Date:  2015-07-08       Impact factor: 6.664

3.  Compensatory Islet Response to Insulin Resistance Revealed by Quantitative Proteomics.

Authors:  Abdelfattah El Ouaamari; Jian-Ying Zhou; Chong Wee Liew; Jun Shirakawa; Ercument Dirice; Nicholas Gedeon; Sevim Kahraman; Dario F De Jesus; Shweta Bhatt; Jong-Seo Kim; Therese Rw Clauss; David G Camp; Richard D Smith; Wei-Jun Qian; Rohit N Kulkarni
Journal:  J Proteome Res       Date:  2015-07-30       Impact factor: 4.466

Review 4.  Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.

Authors:  Steven E Kahn; Mark E Cooper; Stefano Del Prato
Journal:  Lancet       Date:  2013-12-03       Impact factor: 79.321

Review 5.  Lipotoxic diseases.

Authors:  Roger H Unger
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

6.  ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice.

Authors:  Robin Shoemaker; Frederique Yiannikouris; Sean Thatcher; Lisa Cassis
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-08-04       Impact factor: 4.310

7.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Authors:  A Carr; K Samaras; S Burton; M Law; J Freund; D J Chisholm; D A Cooper
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

8.  Exogenous glucose administration impairs glucose tolerance and pancreatic insulin secretion during acute sepsis in non-diabetic mice.

Authors:  Yoshio Watanabe; Srikanth Singamsetty; Baobo Zou; Lanping Guo; Darko Stefanovski; Laura C Alonso; Adolfo Garcia-Ocana; Christopher P O'Donnell; Bryan J McVerry
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

9.  β-cell mass and turnover in humans: effects of obesity and aging.

Authors:  Yoshifumi Saisho; Alexandra E Butler; Erica Manesso; David Elashoff; Robert A Rizza; Peter C Butler
Journal:  Diabetes Care       Date:  2012-08-08       Impact factor: 19.112

10.  Characterisation of age-dependent beta cell dynamics in the male db/db mice.

Authors:  Louise S Dalbøge; Dorthe L C Almholt; Trine S R Neerup; Efstathios Vassiliadis; Niels Vrang; Lars Pedersen; Keld Fosgerau; Jacob Jelsing
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more
  11 in total

1.  Oral Corticosterone Administration Reduces Insulitis but Promotes Insulin Resistance and Hyperglycemia in Male Nonobese Diabetic Mice.

Authors:  Susan J Burke; Heidi M Batdorf; Adrianna E Eder; Michael D Karlstad; David H Burk; Robert C Noland; Z Elizabeth Floyd; J Jason Collier
Journal:  Am J Pathol       Date:  2017-01-04       Impact factor: 4.307

2.  Potent Anti-Inflammatory, Arylpyrazole-Based Glucocorticoid Receptor Agonists That Do Not Impair Insulin Secretion.

Authors:  Brandon J Kennedy; Ashley M Lato; Alexander R Fisch; Susan J Burke; Justin K Kirkland; Carson W Prevatte; Lee E Dunlap; Russell T Smith; Konstantinos D Vogiatzis; J Jason Collier; Shawn R Campagna
Journal:  ACS Med Chem Lett       Date:  2021-09-15       Impact factor: 4.632

3.  Immune regulation of islet homeostasis and adaptation.

Authors:  Jinglong Guo; Wenxian Fu
Journal:  J Mol Cell Biol       Date:  2020-10-01       Impact factor: 6.216

4.  One week of continuous corticosterone exposure impairs hepatic metabolic flexibility, promotes islet β-cell proliferation, and reduces physical activity in male C57BL/6 J mice.

Authors:  Susan J Burke; Heidi M Batdorf; Tai-Yu Huang; Joseph W Jackson; Katarina A Jones; Thomas M Martin; Kristen E Rohli; Michael D Karlstad; Tim E Sparer; David H Burk; Shawn R Campagna; Robert C Noland; Paul L Soto; J Jason Collier
Journal:  J Steroid Biochem Mol Biol       Date:  2019-09-16       Impact factor: 5.011

5.  db/db Mice Exhibit Features of Human Type 2 Diabetes That Are Not Present in Weight-Matched C57BL/6J Mice Fed a Western Diet.

Authors:  Susan J Burke; Heidi M Batdorf; David H Burk; Robert C Noland; Adrianna E Eder; Matthew S Boulos; Michael D Karlstad; J. Jason Collier
Journal:  J Diabetes Res       Date:  2017-09-06       Impact factor: 4.011

6.  Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet β-cell de-differentiation.

Authors:  Susan J Burke; Heidi M Batdorf; David H Burk; Thomas M Martin; Tamra Mendoza; Krisztian Stadler; Wateen Alami; Michael D Karlstad; Matthew J Robson; Randy D Blakely; Randall L Mynatt; J Jason Collier
Journal:  Mol Metab       Date:  2018-06-06       Impact factor: 7.422

7.  Special Issue: Islet Inflammation and Metabolic Homeostasis.

Authors:  Susan J Burke; J Jason Collier
Journal:  Metabolites       Date:  2021-01-28

8.  Botanical Interventions to Improve Glucose Control and Options for Diabetes Therapy.

Authors:  Peter Smoak; Susan J Burke; J Jason Collier
Journal:  SN Compr Clin Med       Date:  2021-08-15

Review 9.  Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence.

Authors:  Aoibhe M Pasieka; Alex Rafacho
Journal:  Metabolites       Date:  2016-08-03

10.  Fenugreek supplementation during high-fat feeding improves specific markers of metabolic health.

Authors:  Eric J Knott; Allison J Richard; Randall L Mynatt; David Ribnicky; Jacqueline M Stephens; Annadora Bruce-Keller
Journal:  Sci Rep       Date:  2017-10-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.